These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. The use of botulinum toxin in blepharospasm. Shorr N; Seiff SR; Kopelman J Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489 [TBL] [Abstract][Full Text] [Related]
36. Use of botulinum toxin in blepharospasm and other facial spasms. Ruusuvaara P; Setälä K Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155 [TBL] [Abstract][Full Text] [Related]
37. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Mauriello JA Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932 [TBL] [Abstract][Full Text] [Related]
38. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm. Wirtschafter JD Ophthalmology; 1991 Mar; 98(3):357-66. PubMed ID: 2023757 [TBL] [Abstract][Full Text] [Related]
39. Treatment of blepharospasm with botulinum toxin. A preliminary report. Frueh BR; Felt DP; Wojno TH; Musch DC Arch Ophthalmol; 1984 Oct; 102(10):1464-8. PubMed ID: 6385932 [TBL] [Abstract][Full Text] [Related]
40. [Pathogenetic effect of the irritants]. Azbukin GV Voen Med Zh; 1982 Nov; (11):52. PubMed ID: 6817513 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]